Stock Overview

Sakar Healthcare Share Price

Sakar Healthcare Share Price

802.2
-25.40 (-3.07%)
24 Jul, 2026 • 03:30 PM
NSE: SAKAR | Pharmaceuticals | Small Cap
Buywith MTF at 1x leverage

Sakar Healthcare Annualised Returns

1 Year

124.71%Increase

3 Years

47.62%Increase

5 Years

34.90%Increase

Sakar Healthcare Share Price Today


As of 26 Jul 2026, Sakar Healthcare share price is ₹802.2. The stock opened at ₹845 and had closed at ₹827.6 the previous day. During today’s trading session, Sakar Healthcare share price moved between ₹785.60 and ₹876.00, with an average price for the day of ₹830.80. Over the last 52 weeks, the stock has recorded a low of ₹311.00 and a high of ₹960.00. In terms of performance, Sakar Healthcare share price has increased by 106.6% over the past six months and has increased by 124.71% over the last year.

Sakar Healthcare Stock Performance

1W Return-8.60%
1M Return-3.10%
6M Return106.65%
1Y Return117.81%
3Y Return210.15%
Today's High₹876
Today's Low₹785.6
52-Week High₹960
52-Week Low₹311
Prev. Close₹827.60
Open₹845.00
Face Value₹10
Mkt Cap (Cr.)₹1,785
PE Ratio58.55

Sakar Healthcare Share Price Chart

Sakar Healthcare Company background

Founded in: 2004
Managing director: Sanjay S Shah.
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, antiemetics, antihistamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHOGMP, CGMP National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started commercial production for Plant 1 which was established for production of Liquid Orals in 2007, it started exporting its products overseas started commercial production for Plant 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup Blactum. / Sachet in 2008. Further, it started commercial production for Plant 3 which was established for production of Liquid Injectibles (SVP) Ampoules and Liquid Injectibles (SVP) Vials.In 2012, it started commercial production for Plant 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 202223, the Company started commercialization with Oncology product post receiving WHO GMP certification.The Company granted a patent for IMATINIB and the EU GMP certification and began oncology unit to export oncology products in FY 2025.

Sakar Healthcare Financial Highlights


For the full year FY2026–2027, revenue reached ₹254.02 crore and profit touched at ₹30.48 crore.
Sakar Healthcare SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 8,11,198 in 5 years with a gain of 5,11,198 (+170.40%)

Sakar Healthcare Fundamental

Market Cap (in crs)

1,784.89

Face Value

10

Turnover (in lacs)

4,390.07

Key Metrics

Qtr Change %
157.94% Gain from 52W Low
27.5
Dividend yield 1yr %
0

Sakar Healthcare Key Financials

View more
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...

Sakar Healthcare Result Highlights

  • Sakar Healthcare reported a 1.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 16.7%.

  • Its expenses for the quarter were up by 0.4% QoQ and 10.9% YoY.

  • The net profit decreased 5.6% QoQ and increased 118.8% YoY.

  • The earnings per share (EPS) of Sakar Healthcare stood at 2.1 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Sakar Healthcare Technical Analysis

Moving Averages Analysis
802.2
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
10
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
837.40
10 EMA
848.90
12 EMA
849.40
20 EMA
844.40
26 EMA
837.00
50 EMA
795.30
100 EMA
708.70
200 EMA
596.00
Delivery & Volume
Loading chart...

Day

20.80%

Week

31.80%

Month

38.30%

Delivery & Volume

821.27
Pivot
Resistance
First Resistance
856.93
Second Resistance
911.67
Third Resistance
947.33
Support
First Support
766.53
Second support
730.87
Third Support
676.13
Relative Strength Index
43.96
Money Flow Index
50.19
MACD
12.46
MACD Signal
21.15
Average True Range
51.44
Average Directional Index
22.76
Rate of Change (21)
-3.10
Rate of Change (125)
96.33
Compare

Sakar Healthcare Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
52.5%
Foreign Institutions
12.1%
Domestic Institutions
11.4%
Public
24%

Sakar Healthcare Latest News

21 MAY 2026

Sakar Healthcare share price in the past 1-year return was 117.81. The Sakar Healthcare share hit a 1-year low of Rs. 311 and a 1-year high of Rs. 960.

The market cap of Sakar Healthcare is Rs. 1784.89 Cr. as of 24/7/2026.

The PE ratios of Sakar Healthcare is 58.55 as of 24/7/2026.

The PB ratios of Sakar Healthcare is 5.49 as of 24/7/2026

You can easily buy Sakar Healthcare shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Sakar Healthcare share price is ₹960 and ₹311 as of 24/7/2026.

Please be aware that Sakar Healthcare stock prices are subject to continuous fluctuations due to various factors.